Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subretinal Haematoma in AMD: Randomized Controlled Study of 2 Therapeutic Approaches in the Antiangiogenic Era

NCT02557451 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT02557451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02557451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subretinal Haematoma in AMD: Randomized Controlled Study of 2 Therapeutic Approaches in the Antiangiogenic Era
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Not applicable
Overall status
Completed
Start date
April 28, 2016
Completion date
Not reported
Enrollment
91 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

subretinal haematoma linked to amd